Heba M. Midan

709 total citations
17 papers, 527 citations indexed

About

Heba M. Midan is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Heba M. Midan has authored 17 papers receiving a total of 527 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Cancer Research and 6 papers in Surgery. Recurrent topics in Heba M. Midan's work include MicroRNA in disease regulation (8 papers), Circular RNAs in diseases (7 papers) and Cancer-related molecular mechanisms research (3 papers). Heba M. Midan is often cited by papers focused on MicroRNA in disease regulation (8 papers), Circular RNAs in diseases (7 papers) and Cancer-related molecular mechanisms research (3 papers). Heba M. Midan collaborates with scholars based in Egypt, Saudi Arabia and Japan. Heba M. Midan's co-authors include Ahmed S. Doghish, Mohammed S. Elballal, Mahmoud A. Elrebehy, Reem K. Shahin, Ola Elazazy, Ahmed E. Elesawy, Al-Aliaa M. Sallam, Ahmed I. Abulsoud, Sherif S. Abdel Mageed and Nourhan M. Abdelmaksoud and has published in prestigious journals such as Experimental Cell Research, The Journal of Gene Medicine and Pathology - Research and Practice.

In The Last Decade

Heba M. Midan

16 papers receiving 527 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Heba M. Midan Egypt 15 397 374 76 63 58 17 527
Reem K. Shahin Egypt 11 310 0.8× 291 0.8× 57 0.8× 55 0.9× 44 0.8× 14 412
Ola Elazazy Egypt 11 292 0.7× 272 0.7× 53 0.7× 48 0.8× 41 0.7× 18 416
Susanne Raulefs Germany 9 236 0.6× 314 0.8× 142 1.9× 57 0.9× 34 0.6× 21 451
Manuela Lanzafame Italy 11 200 0.5× 342 0.9× 67 0.9× 19 0.3× 47 0.8× 21 496
Jovanna González Spain 10 674 1.7× 742 2.0× 52 0.7× 24 0.4× 60 1.0× 15 840
Jasmien Hoebeeck Belgium 12 154 0.4× 326 0.9× 89 1.2× 23 0.4× 47 0.8× 15 476
Zhining Fan China 9 380 1.0× 395 1.1× 40 0.5× 29 0.5× 77 1.3× 11 505
Xiao Albert Zhou China 8 242 0.6× 366 1.0× 82 1.1× 17 0.3× 42 0.7× 14 512
Ashton C. Berger United States 7 132 0.3× 340 0.9× 63 0.8× 33 0.5× 26 0.4× 13 440
Haitao Zhang China 11 172 0.4× 221 0.6× 53 0.7× 23 0.4× 38 0.7× 25 340

Countries citing papers authored by Heba M. Midan

Since Specialization
Citations

This map shows the geographic impact of Heba M. Midan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heba M. Midan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heba M. Midan more than expected).

Fields of papers citing papers by Heba M. Midan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heba M. Midan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heba M. Midan. The network helps show where Heba M. Midan may publish in the future.

Co-authorship network of co-authors of Heba M. Midan

This figure shows the co-authorship network connecting the top 25 collaborators of Heba M. Midan. A scholar is included among the top collaborators of Heba M. Midan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heba M. Midan. Heba M. Midan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Midan, Heba M., et al.. (2026). miRNA‐Directed Anticancer Strategies: The Emerging Role of Natural Products in Ovarian Cancer. The Journal of Gene Medicine. 28(1). e70080–e70080.
2.
Elsakka, Elsayed G.E., Heba M. Midan, Ahmed I. Abulsoud, et al.. (2024). Emerging insights: miRNA modulation of ferroptosis pathways in lung cancer. Experimental Cell Research. 442(2). 114272–114272. 7 indexed citations
3.
Yehia, Amr Mohamed, Elsayed G.E. Elsakka, Ahmed I. Abulsoud, et al.. (2023). miRNAs driving diagnosis, progression, and drug resistance in multiple myeloma. Pathology - Research and Practice. 248. 154704–154704. 25 indexed citations
4.
Doghish, Ahmed S., Mohammed S. Elballal, Ola Elazazy, et al.. (2023). miRNAs as potential game-changers in bone diseases: Future medicinal and clinical uses. Pathology - Research and Practice. 245. 154440–154440. 54 indexed citations
5.
AL‐Noshokaty, Tohada M., Mohammed S. Elballal, Gouda K. Helal, et al.. (2023). miRNAs driving diagnosis, prognosis and progression in Merkel cell carcinoma. Pathology - Research and Practice. 249. 154763–154763. 20 indexed citations
6.
Doghish, Ahmed S., Mohammed S. Elballal, Al-Aliaa M. Sallam, et al.. (2023). The potential role of miRNAs in the pathogenesis of testicular germ cell tumors - A Focus on signaling pathways interplay. Pathology - Research and Practice. 248. 154611–154611. 27 indexed citations
7.
Elsakka, Elsayed G.E., Ahmed I. Abulsoud, Hesham A. El‐Mahdy, et al.. (2023). miRNAs orchestration of cardiovascular diseases – Particular emphasis on diagnosis, and progression. Pathology - Research and Practice. 248. 154613–154613. 30 indexed citations
8.
Rizk, Nehal I., Heba M. Midan, Gouda K. Helal, et al.. (2023). The emerging role of miRNAs in Merkel cell carcinoma pathogenesis: Signaling pathway crosstalk. Pathology - Research and Practice. 249. 154771–154771. 21 indexed citations
9.
Elesawy, Ahmed E., Ahmed I. Abulsoud, Mohammed S. Elballal, et al.. (2023). miRNAs orchestration of testicular germ cell tumors – Particular emphasis on diagnosis, progression and drug resistance. Pathology - Research and Practice. 248. 154612–154612. 28 indexed citations
10.
Shahin, Reem K., Ahmed I. Abulsoud, Nourhan M. Abdelmaksoud, et al.. (2023). miRNAs orchestration of gallbladder cancer – Particular emphasis on diagnosis, progression and drug resistance. Pathology - Research and Practice. 248. 154684–154684. 30 indexed citations
11.
Doghish, Ahmed S., Heba M. Midan, Abdullah M. M. Elbadry, et al.. (2023). The potential role of miRNAs in the pathogenesis of gallbladder cancer – A focus on signaling pathways interplay. Pathology - Research and Practice. 248. 154682–154682. 28 indexed citations
12.
Elazazy, Ola, Heba M. Midan, Reem K. Shahin, et al.. (2023). Long non-coding RNAs and rheumatoid arthritis: Pathogenesis and clinical implications. Pathology - Research and Practice. 246. 154512–154512. 49 indexed citations
13.
Khidr, Emad Gamil, Ahmed I. Abulsoud, Hesham A. El‐Mahdy, et al.. (2023). The potential role of miRNAs in the pathogenesis of cardiovascular diseases – A focus on signaling pathways interplay. Pathology - Research and Practice. 248. 154624–154624. 34 indexed citations
14.
El‐Dakroury, Walaa A., Heba M. Midan, Ahmed I. Abulsoud, et al.. (2023). miRNAs orchestration of adrenocortical carcinoma - Particular emphasis on diagnosis, progression and drug resistance. Pathology - Research and Practice. 248. 154665–154665. 24 indexed citations
15.
Doghish, Ahmed S., Mohammed S. Elballal, Ola Elazazy, et al.. (2023). The role of miRNAs in liver diseases: Potential therapeutic and clinical applications. Pathology - Research and Practice. 243. 154375–154375. 76 indexed citations
16.
Elballal, Mohammed S., Al-Aliaa M. Sallam, Ahmed E. Elesawy, et al.. (2023). miRNAs as potential game-changers in renal cell carcinoma: Future clinical and medicinal uses. Pathology - Research and Practice. 245. 154439–154439. 52 indexed citations
17.
Midan, Heba M., Gouda K. Helal, Ahmed I. Abulsoud, et al.. (2023). The potential role of miRNAs in the pathogenesis of adrenocortical carcinoma – A focus on signaling pathways interplay. Pathology - Research and Practice. 248. 154690–154690. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Reem K. Shahin Breakdown of academic impact, for papers by Ola Elazazy Breakdown of academic impact, for papers by Susanne Raulefs Breakdown of academic impact, for papers by Manuela Lanzafame Breakdown of academic impact, for papers by Jovanna González Breakdown of academic impact, for papers by Jasmien Hoebeeck Breakdown of academic impact, for papers by Zhining Fan Breakdown of academic impact, for papers by Xiao Albert Zhou Breakdown of academic impact, for papers by Ashton C. Berger Breakdown of academic impact, for papers by Haitao Zhang
Rankless by CCL
2026